On Invalid Date, Applied Therapeutics (NASDAQ: APLT) reported Q4 2023 earnings per share (EPS) of -$0.33, up 106.25% year over year. Total Applied Therapeutics earnings for the quarter were -$37.68 million. In the same quarter last year, Applied Therapeutics's earnings per share (EPS) was -$0.16.
As of Q2 2024, Applied Therapeutics's earnings has grown year over year. Applied Therapeutics's earnings in the past year totalled -$119.76 million.
What is APLT's earnings date?
Applied Therapeutics's earnings date is Invalid Date. Add APLT to your watchlist to be reminded of APLT's next earnings announcement.
What was APLT's revenue last quarter?
On Invalid Date, Applied Therapeutics (NASDAQ: APLT) reported Q4 2023 revenue of -$667.00 thousand up Infinity% year over year. In the same quarter last year, Applied Therapeutics's revenue was $0.00.
What was APLT's revenue growth in the past year?
As of Q2 2024, Applied Therapeutics's revenue has grown null year over year. Applied Therapeutics's revenue in the past year totalled $9.99 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.